Document Detail


ACE inhibitors and cardiac ACE mRNA in volume overload-induced cardiac hypertrophy.
MedLine Citation:
PMID:  9277479     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Quinapril, an angiotensin-converting enzyme (ACE) inhibitor with high affinity for cardiac ACE, prevents increases in both plasma and cardiac angiotensin II (ANG II) and development of cardiac hypertrophy after aortocaval shunt in rats. In contrast, enalapril, an ACE inhibitor with low affinity for cardiac ACE, only prevents the increase in plasma ANG II. In the present study, we assessed whether these differences between enalapril and quinapril reflect different inhibition of cardiac tissue ACE and local ANG II by measuring their effects on cardiac ACE mRNA. Treatment with enalapril (250 mg/l) and quinapril (200 mg/l in drinking water) was started 3 days before the shunt and sham surgery. After 1 wk of aortocaval shunt, the hearts were excised and the left ventricle and right ventricle were weighed and used for reverse transcriptase-polymerase chain reaction (RT-PCR) assays for ACE and phosphoglycerate kinase-1 (internal standard). Quinapril, but not enalapril, inhibited the development of cardiac hypertrophy by aortocaval shunt. The shunt increased ACE mRNA in both left and right ventricles about twofold. In animals with aortocaval shunt, quinapril markedly further upregulated ACE mRNA in both ventricles, whereas enalapril did not cause significant changes. In sham rats, both ACE inhibitors increased ACE mRNA, but the increase was more pronounced by treatment with quinapril. These studies show that in vivo ACE inhibitors with low (enalapril) vs. high (quinapril) affinity for cardiac ACE differ in their effects on cardiac ACE mRNA. This difference is more pronounced in volume overload-induced cardiac hypertrophy, presumably reflecting their different effects on cardiac ANG II.
Authors:
W Lear; M Ruzicka; F H Leenen
Related Documents :
15462689 - Provision of cardiovascular protection by ace inhibitors: a review of recent trials.
22270539 - Predictors of long-term benefit of cardiac resynchronization therapy in patients with r...
12904089 - Carvedilol: a review of its use in chronic heart failure.
22337219 - Achieving high quality in st-segment elevation myocardial infarction care: one urban ac...
1977779 - Relation between beta-adrenergic blocker use, various correlates of left ventricular fu...
22825919 - A primer on arrhythmias in patients with hypertrophic cardiomyopathy.
20491649 - The cardiovascular nutrapharmacology of resveratrol: pharmacokinetics, molecular mechan...
20030529 - Factors related to silent myocardial damage in hemodialysis patients.
19389719 - Clinical characteristics of patients with obstructive coronary lesions in the absence o...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The American journal of physiology     Volume:  273     ISSN:  0002-9513     ISO Abbreviation:  Am. J. Physiol.     Publication Date:  1997 Aug 
Date Detail:
Created Date:  1997-09-25     Completed Date:  1997-09-25     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0370511     Medline TA:  Am J Physiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  H641-6     Citation Subset:  IM    
Affiliation:
Hypertension Unit, University of Ottawa Heart Institute, Ontario, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angiotensin-Converting Enzyme Inhibitors / pharmacology*
Animals
Cardiomegaly / etiology*,  metabolism*,  pathology
Enalapril / pharmacology
Heart Ventricles
Hyperemia / complications*
Isoquinolines / pharmacology
Male
Myocardium / metabolism*,  pathology
Organ Size
Peptidyl-Dipeptidase A / genetics*
RNA, Messenger / metabolism*
Rats
Rats, Wistar
Tetrahydroisoquinolines*
Chemical
Reg. No./Substance:
0/Angiotensin-Converting Enzyme Inhibitors; 0/Isoquinolines; 0/RNA, Messenger; 0/Tetrahydroisoquinolines; 75847-73-3/Enalapril; 82586-55-8/quinapril; EC 3.4.15.1/Peptidyl-Dipeptidase A

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  alpha-Tocopheryl succinate inhibits monocytic cell adhesion to endothelial cells by suppressing NF-k...
Next Document:  Effects of high-cholesterol and atherogenic diets on vascular relaxation in spontaneously hypertensi...